倍氯米松/福莫特罗/格隆溴铵
| 组成 | |
|---|---|
| 二丙酸倍氯米松 | 糖皮质激素 |
| 延胡索酸福莫特罗二水合物 | 长效β2激动剂 |
| 格隆溴铵 | 抗毒蕈碱剂 |
| 临床资料 | |
| 商品名 | Trimbow、Trydonis、Riarify等等 |
| AHFS/Drugs.com | 英国药物信息 |
| 给药途径 | 吸入 |
| ATC码 | |
| 法律规范状态 | |
| 法律规范 |
|
| 识别信息 | |
| CAS号 | 2447629-85-6 |
倍氯米松/福莫特罗/格隆铵，以Trimbow等商品名销售，是一种用于治疗慢性阻塞性肺病（COPD）和哮喘的吸入式固定剂量复方药。它含有二丙酸倍氯米松、延胡索酸福莫特罗二水合物和格隆溴铵。[3][4]
副作用包括口腔念珠菌症（由念珠菌引起的口腔真菌感染）、肌肉痉挛和口干。[3][4]
倍氯米松/福莫特罗/格隆铵于2017年7月和2018年4月在欧盟获准使用。[3][4][5]
参考资料
[编辑]- ^ Trimbow ARTG ID 314166. Therapeutic Goods Administration (TGA). [21 July 2020].[失效链接]
- ^ Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution - Summary of Product Characteristics (SmPC). (emc). 8 February 2019 [5 March 2020]. （原始内容存档于2024-03-04）.
- ^ 3.0 3.1 3.2 Trimbow EPAR. European Medicines Agency (EMA). 5 March 2020 [5 March 2020]. （原始内容存档于2024-05-23）. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ 4.0 4.1 4.2 Trydonis EPAR. European Medicines Agency (EMA). 21 July 2020 [21 July 2020]. （原始内容存档于2024-03-06）. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ Riarify EPAR. European Medicines Agency (EMA). [21 July 2020]. （原始内容存档于2023-11-29）.
外部链接
[编辑]- Beclometasone dipropionate. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. （原始内容存档于2022-10-02）.
- Formoterol. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. （原始内容存档于2021-03-31）.
- Glycopyrronium bromide. Drug Information Portal. U.S. National Library of Medicine. [2023-12-08]. （原始内容存档于2020-02-29）.